Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT)

Pharmaceutical Preparations

https://www.arcturusrx.com

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.

10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/22/2013

Market Cap

539,491,890

Shares Outstanding

26,720,000

Weighted SO

26,723,332

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

ETNB --.--%

MDGL --.--%

PLRX --.--%

ACLX --.--%

STOK --.--%

NTLA --.--%

BEAM --.--%

CRBU --.--%

CRSP --.--%

Beta

2.6410

Last Div

0.0000

Range

17.52-45.0

Chg

-0.3100

Avg Vol

593841

Mkt Cap

539491890

Exch

NASDAQ

Country

US

Phone

858 900 2660

DCF Diff

53.0924

DCF

-26.4324

Div Yield

0.0000

P/S

3.5927

EV Multiple

-4.4832

P/FV

2.0805

Div Yield %

0.0000

P/E

-7.8165

PEG

-0.5999

Payout

0.0000

Current Ratio

3.7835

Quick Ratio

3.7835

Cash Ratio

3.4381

DSO

58.5436

DIO

-0.0001

Op Cycle

58.5435

DPO

-1750.7158

CCC

1809.2592

Gross Margin

1.0193

Op Margin

-0.4230

Pretax Margin

-0.4492

Net Margin

-0.4584

Eff Tax Rate

-0.0204

ROA

-0.1771

ROE

-0.2547

ROCE

-0.2140

NI/EBT

1.0204

EBT/EBIT

1.0619

EBIT/Rev

-0.4230

Debt Ratio

0.0795

D/E

0.1194

LT Debt/Cap

0.0944

Total Debt/Cap

0.1067

Int Coverage

-2646.6667

CF/Debt

-2.2136

Equity Multi

1.5028

Rec Turnover

6.2347

Pay Turnover

-0.2085

Inv Turnover

-999999.9999

FA Turnover

3.7810

Asset Turnover

0.3864

OCF/Share

-2.5348

FCF/Share

-2.6232

Cash/Share

11.6931

OCF/Sales

-0.4552

FCF/OCF

1.0348

CF Coverage

-2.2136

ST Coverage

-17.4514

CapEx Coverage

-28.7043

Div&CapEx Cov

-28.7043

P/BV

2.0805

P/B

2.0805

P/S

3.5927

P/E

-7.8165

P/FCF

-7.6266

P/OCF

-7.8703

P/CF

-7.8703

PEG

-0.5999

P/S

3.5927

EV Multiple

-4.4832

P/FV

2.0805

DPS

0.0000

Latest Headlines (EST)

Benzinga Jun 26, 02:27 Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival Benzinga Dec 13, 13:34 Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.01 01/08/2013 12/27/2012 01/08/2013 01/15/2013
0.01 01/04/2013 12/27/2012 01/08/2013 01/15/2013
0.01 12/05/2012 11/28/2012 11/30/-0001 12/15/2012
0.01 11/06/2012 10/26/2012 11/30/-0001 11/15/2012
0.01 10/03/2012 09/27/2012 11/30/-0001 10/15/2012
0.01 09/05/2012 08/01/2012 11/30/-0001 09/15/2012
0.01 08/06/2012 07/26/2012 11/30/-0001 08/15/2012
0.01 07/03/2012 06/27/2012 11/30/-0001 07/15/2012
0.01 06/06/2012 05/29/2012 11/30/-0001 06/15/2012
0.01 05/04/2012 04/27/2012 11/30/-0001 05/15/2012
0.01 04/03/2012 03/14/2012 11/30/-0001 04/15/2012
0.00 03/06/2012 03/02/2012 11/30/-0001 03/15/2012